financetom
OM
financetom
/
Healthcare
/
OM
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Outset Medical, Inc.OM
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis.

It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings.

The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015.

Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Latest News >
Timken to Sell Belts Business to Gates
Timken to Sell Belts Business to Gates
May 1, 2026
Action consistent with company's portfolio 80/20 approachExpected to improve adjusted EBITDA margins of Industrial Motion segment NORTH CANTON, Ohio, May 1, 2026 /PRNewswire/ -- The Timken Company ( TKR ) , a global technology leader in engineered bearings and industrial motion, today announced that it has entered into a definitive agreement to sell the assets of its belts business to...
Top Premarket Gainers
Top Premarket Gainers
May 1, 2026
07:51 AM EDT, 05/01/2026 (MT Newswires) -- Cue Biopharma ( CUE ) shares were 98% higher in Friday premarket activity, a day after the company said it signed a roughly $30 million PIPE financing with certain investors, and also appointed Shao-Lee Lin as president and chief executive. Reddit ( RDDT ) stock was up 15% after the company posted Thursday...
Federal Realty Investment Trust Q1 Core FFO, Revenue Rise; Lifts 2026 Core FFO Outlook
Federal Realty Investment Trust Q1 Core FFO, Revenue Rise; Lifts 2026 Core FFO Outlook
May 1, 2026
08:00 AM EDT, 05/01/2026 (MT Newswires) -- Federal Realty Investment Trust ( FRT ) reported Q1 core funds from operations Friday of $1.88 per diluted share, up from $1.70 a year earlier. Analysts polled by FactSet expected $1.80. Total revenue for the three months ended March 31 was $341.1 million, up from $309.2 million a year earlier. Analysts surveyed by...
Ares' record $30 billion fundraising eases private credit 'doomsday' fears
Ares' record $30 billion fundraising eases private credit 'doomsday' fears
May 1, 2026
* Ares on track for record year of fundraising, CEO Arougheti says * Private credit behemoth logs record $30 billion fundraise in Q1 * Ares sitting on record investment pipeline * Uninvested capital swells to $158 billion (Adds analyst comment in paragraph 8, deal background in paragraph 13) By Arasu Kannagi Basil and Pritam Biswas May 1 (Reuters) - Ares...
Copyright 2023-2026 - www.financetom.com All Rights Reserved